Blockchain Registration Transaction Record

Cardio Diagnostics to Showcase AI Heart Risk Tools at Benefits Conferences

Cardio Diagnostics (CDIO) to exhibit AI-powered cardiovascular risk assessments at benefits conferences, targeting employer health plan cost reduction.

Cardiovascular disease remains the leading cause of death and a major cost driver for employers and health plans. By presenting its AI-powered risk assessment platforms at national benefits conferences, Cardio Diagnostics is directly addressing the need for earlier identification and management of at-risk individuals. This matters because proactive cardiovascular risk management can reduce healthcare costs, improve workforce productivity, and save lives. Benefits decision-makers who adopt these tools may gain a competitive edge in managing their population's health and controlling expenses.